Royalty Pharma

RPRX

Market cap $17.1B

Buy

Hold

Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

Avg. target

$48

20% upside

High target

positive

0 neutral

negative

Analyst & Firm	Rating	Price Target	Upside Downside	Date
Morgan Stanley Terence Flynn 100% 1-yr RPRX win rate				10 Oct ‘25 1 month ago
Goldman Sachs Asad Haider 100% 1-yr RPRX win rate				30 Sep ‘25 2 months ago